Psychopharmacological Treatment of Schizophrenia over time in 30,908 inpatients - Data from the AMSP study - Articles - Neurology · Psychiatry

Psychosis and Schizophrenia

The critical treatment window of clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study.

Psychiatry Res.

Yoshimura B, Yada Y, So R, Takaki M, Yamada N

doi: 10.1016/

Aging and Cognitive FunctionsPsychosis and Schizophrenia

A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits

Transl Psychiatry.

Habtewold TD, Rodijk LH, Liemburg EJ, Sidorenkov G, Boezen HM, Bruggeman R, Alizadeh BZ

doi: 10.1038/s41398-020-00919-x.

COMMENTED

Multiple Sclerosis

Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland

Mult Scler J Exp Transl Clin.

Kaufmann M, Kuhle J, Puhan MA, Kamm CP, Chan A, Salmen A, Kesselring J, Calabrese P, Gobbi C, Pot C, Steinemann N, Rodgers S, von Wyl V; Swiss Multiple Sclerosis Registry (SMSR)

doi: 10.1177/2055217318814562.

Psychosis and Schizophrenia

Association of Secondary Preventive Cardiovascular Treatment After Myocardial Infarction With Mortality Among Patients With Schizophrenia

JAMA Psychiatry.

Kugathasan P, Horsdal HT, Aagaard J, Jensen SE, Laursen TM, Nielsen RE

doi: 10.1001/jamapsychiatry.

RECOMMENDED

Bipolar DisorderPsychosis and Schizophrenia

The Danish High Risk and Resilience Study-VIA 11: Study Protocol for the First Follow-Up of the VIA 7 Cohort -522 Children Born to Parents With Schizophrenia Spectrum Disorders or Bipolar Disorder and Controls Being Re-examined for the First Time at Age 11

Front Psychiatry.

Thorup AAE, Hemager N, Søndergaard A, Gregersen M, Prøsch ÅK, Krantz MF, Brandt JM, Carmichael L, Melau M, Ellersgaard DV, Burton BK, Greve AN, Uddin MJ, Ohland J, Nejad AB, Johnsen LK, Ver Loren van Themaat AH, Andreassen AK, Vedum L, Knudsen CB, Stadsgaard H, M Jepsen JR, Siebner HR, Østergaard L, Bliksted VF, Plessen KJ, Mors O, Nordentoft M

doi: 10.3389/fpsyt.2018.

EpilepsyPsychosis and Schizophrenia

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

Lancet Psychiatry.

Kahn RS, Winter van Rossum , Leucht S, McGuire P, Lewis SW, Leboyer M, Arango C, Dazzan P, Drake R, Heres S, Díaz-Caneja CM, Rujescu D, Weiser M, Galderisi S, Glenthøj B, Eijkemans MJC, Fleischhacker WW, Kapur S, Sommer IE; OPTiMiSE study group

doi: 10.1016/

Psychosis and Schizophrenia

Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis

Lancet Psychiatry.

Rubio JM, Schoretsanitis G, John M, Tiihonen J, Taipale H, Guinart D, Malhotra AK, Correll CU, Kane JM

doi: 10.1016/S2215-0366(20)30264-9.

Premature Mortality Among Patients Recently Discharged From Their First Inpatient Psychiatric Treatment

JAMA Psychiatry.

Walter F, Carr MJ, Mok PL, Astrup A, Antonsen S, Pedersen CB, Shaw J, Webb RT

doi: 10.1001/jamapsychiatry.

Migraine and Headache

Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies

Headache.

Ashina M, Vasudeva R, Jin L, Lombard L, Gray E, Doty EG, Yunes-Medina L, Kinchen KS, Tassorelli C

doi: 10.1111/head.13636.

Related content

The critical treatment window of clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study.

A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits

Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland

Association of Secondary Preventive Cardiovascular Treatment After Myocardial Infarction With Mortality Among Patients With Schizophrenia

The Danish High Risk and Resilience Study-VIA 11: Study Protocol for the First Follow-Up of the VIA 7 Cohort -522 Children Born to Parents With Schizophrenia Spectrum Disorders or Bipolar Disorder and Controls Being Re-examined for the First Time at Age 11

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis

Premature Mortality Among Patients Recently Discharged From Their First Inpatient Psychiatric Treatment

Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies